Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, January 1, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Medtech
RevBio Launches UK Clinical Trial for Regenerative Bone Adhesive in Cranial Surgery
Life Sciences Times
-
May 30, 2025
0
People on the Move
TriSalus Life Sciences Names David B. Patience as New Chief Financial Officer
Life Sciences Times
-
May 30, 2025
0
Legal
UroGen Pharma Faces Securities Fraud Lawsuit After FDA Rejects Key Cancer Drug Application
Life Sciences Times
-
May 30, 2025
0
Healthcare
Octave Bioscience Strengthens Medical Leadership to Advance Precision Neurology in MS and Neurodegenerative Disease
Life Sciences Times
-
May 30, 2025
0
Biotech
Cellares and Mitsui Fudosan to Launch Japan’s First Commercial-Scale Smart Factory for Cell Therapy Manufacturing
Life Sciences Times
-
May 30, 2025
0
Pharma
Agenus Unveils Promising ASCO Data on Botensilimab’s Immune Activation in Colorectal Cancer
Life Sciences Times
-
May 30, 2025
0
Biotech
Bruker Unveils timsOmni™ Mass Spectrometer, Ushering in New Era of Functional Proteoformics
Life Sciences Times
-
May 30, 2025
0
Healthcare
Atropos Health Strengthens Oncology Focus with Key Hires and Expanded Data Capabilities
Life Sciences Times
-
May 30, 2025
0
Biotech
ConcertAI Unveils AI-Powered Precision Suite to Revolutionize Oncology Research and Life Sciences
Life Sciences Times
-
May 30, 2025
0
Venture Capital
Vivodyne Raises $40 Million to Replace Animal Testing with AI-Powered Human Tissue Models
Life Sciences Times
-
May 29, 2025
0
1
...
129
130
131
...
776
Page 130 of 776
Most Popular
Delcath Data Reveals HEPZATO KIT Benefits Patients Across All Subgroups
December 31, 2025
Biobeat Secures $50 Million to Replace the Blood Pressure Cuff with Wearable Patch Technology
December 31, 2025
Verastem Oncology Discontinues RAMP 203 Trial to Prioritize KRAS G12D Program
December 30, 2025
Vicarious Surgical Partners With Global Software Firm to Streamline Development Operations
December 30, 2025
Load more
Recent Comments
Recent Comments